Wednesday, 18 March 2015

Cardiovascular screening in men with ED could save billions




Cardiovascular screening in men with ED could save billions


(HealthDay)—Screening men presenting with erectile dysfunction (ED) for cardiovascular disease (CVD) risk factors can potentially cut future cardiovascular events and save billions of dollars over 20 years, according to a study published online March 2 in The Journal of Sexual Medicine.


Alexander W. Pastuszak, M.D., Ph.D., from the Baylor College of Medicine in Houston, and colleagues evaluated the long-term effect of screening men presenting with ED for CVD risk factors. The authors sought to determine the of such a screening protocol.


The researchers found that the relative risk of ED in men with CVD is 1.47, with the coprevalence of ED and CVD estimated to affect 1,991,520 men. Roughly 44 percent of men with CVD risk factors are not aware that they have them. Screening all men presenting with ED for CVD would identify 5.8 million men with previously unknown CVD risk factors over 20 years and would cost $2.7 billion. Avoidance of 1.1 million cardiovascular events is possible if there is a 20 percent decrease in events due to screening and treatment, saving $21.3 billion over 20 years. If the $9.7 billion savings from treating 1.1 million cases of ED is factored in, the combined reduction in acute CVD and ED treatment cost would equal savings of $28.5 billion over 20 years.


"Screening for CVD in men presenting with ED can be a cost-effective intervention for secondary prevention of both CVD and, over the longer term, ED," the authors write.



More information: Abstract

Full Text


Copyright © 2015 HealthDay. All rights reserved.


Medical Xpress on facebook

Related Stories


Study highlights benefits of screening for heart disease in men with erectile dysfunction


Mar 02, 2015



New research reveals that screening for cardiovascular disease in men presenting with erectile dysfunction may be a cost-effective intervention for preventing both cardiovascular disease and, over the longer term, erectile ...



Increasing severity of erectile dysfunction is a marker for increasing risk of cardiovascular disease and death


Jan 29, 2013



A large study published in PLOS Medicine on January 29, 2013, shows that the risk of future cardiovascular disease and death increased with severity of erectile dysfunction in men both with and without a history of cardio ...



CVD risk up with androgen deprivation Tx in prostate cancer


Mar 11, 2015



(HealthDay)—For men with prostate cancer (PCa), the risk for incident cardiovascular disease (CVD) is increased with androgen deprivation therapy (ADT), according to a study published online March 2 in ...



Managing erectile dysfunction, comorbid diseases linked


Dec 03, 2012



(HealthDay)—Diagnosis and management of erectile dysfunction (ED) improves health outcomes for men with comorbid diseases, and vice versa, according to research published online Nov. 15 in The Journal of ...



Guidance issued for erectile dysfunction as marker of CVD


Jul 23, 2013



(HealthDay)—Erectile dysfunction (ED) has predictive value for cardiovascular risk and treatment may have beneficial effects, according to research published in the June issue of The Journal of Urology.



Recommended for you




Researchers describe new approach to promote regeneration of heart tissue


2 hours ago



The heart tissue of mammals has limited capacity to regenerate after an injury such as a heart attack, in part due to the inability to reactivate a cardiac muscle cell and proliferation program. Recent studies ...





Healthy diet reduces risk of cardiovascular disease by a third in over-40s


4 hours ago



Men and women who adapt their daily diet to meet current UK dietary guidelines could reduce their risk of a heart attack or a stroke by up to a third, according to a new study by King's College London.



Use of anti-clotting drug more than three hours after stroke should be re-evaluated, say researchers


21 hours ago



Advice to use the anti-clotting drug alteplase more than three hours after an acute stroke should be re-evaluated, say researchers writing in The BMJ this week.



Decline in heart health can start in childhood


Mar 17, 2015



Your heart health, which is optimal for most of us at birth, can decline substantially with unhealthy childhood behaviors, according to research in Circulation: Cardiovascular Quality and Outcomes, an American Heart Associ ...



Duration of antiplatelet therapy following PCI, risk of adverse events


Mar 17, 2015



An additional 18 months of dual antiplatelet therapy among patients who received a bare metal coronary stent did not result in significant differences in rates of stent thrombosis (formation of a blood clot), major adverse ...



Trial of bivalirudin during angioplasty reports mixed results


Mar 17, 2015



Patients with acute coronary syndrome undergoing angioplasty who received the anticoagulant drug bivalirudin did not show significant improvements in either of two co-primary endpoints—a composite of rate of death, heart ...



User comments



Please sign in to add a comment. Registration is free, and takes less than a minute. Read more


Click here to reset your password.

Sign in to get notified via email when new comments are made.







Cardiovascular screening in men with ED could save billions


(HealthDay)—Screening men presenting with erectile dysfunction (ED) for cardiovascular disease (CVD) risk factors can potentially cut future cardiovascular events and save billions of dollars over 20 years, according to a study published online March 2 in The Journal of Sexual Medicine.


Alexander W. Pastuszak, M.D., Ph.D., from the Baylor College of Medicine in Houston, and colleagues evaluated the long-term effect of screening men presenting with ED for CVD risk factors. The authors sought to determine the of such a screening protocol.


The researchers found that the relative risk of ED in men with CVD is 1.47, with the coprevalence of ED and CVD estimated to affect 1,991,520 men. Roughly 44 percent of men with CVD risk factors are not aware that they have them. Screening all men presenting with ED for CVD would identify 5.8 million men with previously unknown CVD risk factors over 20 years and would cost $2.7 billion. Avoidance of 1.1 million cardiovascular events is possible if there is a 20 percent decrease in events due to screening and treatment, saving $21.3 billion over 20 years. If the $9.7 billion savings from treating 1.1 million cases of ED is factored in, the combined reduction in acute CVD and ED treatment cost would equal savings of $28.5 billion over 20 years.


"Screening for CVD in men presenting with ED can be a cost-effective intervention for secondary prevention of both CVD and, over the longer term, ED," the authors write.



More information: Abstract

Full Text


Copyright © 2015 HealthDay. All rights reserved.


Medical Xpress on facebook

Related Stories


Study highlights benefits of screening for heart disease in men with erectile dysfunction


Mar 02, 2015



New research reveals that screening for cardiovascular disease in men presenting with erectile dysfunction may be a cost-effective intervention for preventing both cardiovascular disease and, over the longer term, erectile ...



Increasing severity of erectile dysfunction is a marker for increasing risk of cardiovascular disease and death


Jan 29, 2013



A large study published in PLOS Medicine on January 29, 2013, shows that the risk of future cardiovascular disease and death increased with severity of erectile dysfunction in men both with and without a history of cardio ...



CVD risk up with androgen deprivation Tx in prostate cancer


Mar 11, 2015



(HealthDay)—For men with prostate cancer (PCa), the risk for incident cardiovascular disease (CVD) is increased with androgen deprivation therapy (ADT), according to a study published online March 2 in ...



Managing erectile dysfunction, comorbid diseases linked


Dec 03, 2012



(HealthDay)—Diagnosis and management of erectile dysfunction (ED) improves health outcomes for men with comorbid diseases, and vice versa, according to research published online Nov. 15 in The Journal of ...



Guidance issued for erectile dysfunction as marker of CVD


Jul 23, 2013



(HealthDay)—Erectile dysfunction (ED) has predictive value for cardiovascular risk and treatment may have beneficial effects, according to research published in the June issue of The Journal of Urology.



Recommended for you




Researchers describe new approach to promote regeneration of heart tissue


2 hours ago



The heart tissue of mammals has limited capacity to regenerate after an injury such as a heart attack, in part due to the inability to reactivate a cardiac muscle cell and proliferation program. Recent studies ...





Healthy diet reduces risk of cardiovascular disease by a third in over-40s


4 hours ago



Men and women who adapt their daily diet to meet current UK dietary guidelines could reduce their risk of a heart attack or a stroke by up to a third, according to a new study by King's College London.



Use of anti-clotting drug more than three hours after stroke should be re-evaluated, say researchers


21 hours ago



Advice to use the anti-clotting drug alteplase more than three hours after an acute stroke should be re-evaluated, say researchers writing in The BMJ this week.



Decline in heart health can start in childhood


Mar 17, 2015



Your heart health, which is optimal for most of us at birth, can decline substantially with unhealthy childhood behaviors, according to research in Circulation: Cardiovascular Quality and Outcomes, an American Heart Associ ...



Duration of antiplatelet therapy following PCI, risk of adverse events


Mar 17, 2015



An additional 18 months of dual antiplatelet therapy among patients who received a bare metal coronary stent did not result in significant differences in rates of stent thrombosis (formation of a blood clot), major adverse ...



Trial of bivalirudin during angioplasty reports mixed results


Mar 17, 2015



Patients with acute coronary syndrome undergoing angioplasty who received the anticoagulant drug bivalirudin did not show significant improvements in either of two co-primary endpoints—a composite of rate of death, heart ...



User comments



Please sign in to add a comment. Registration is free, and takes less than a minute. Read more


Click here

to reset your password.


Sign in to get notified via email when new comments are made.









Categories:

0 comments:

Post a Comment